Detalhe da pesquisa
1.
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.
Oncologist
; 26(6): 483-491, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586274
2.
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.
Cancer
; 118(4): 981-6, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792865
3.
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
Invest New Drugs
; 28(4): 523-8, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19547919
4.
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.
J Clin Oncol
; 34(21): 2478-83, 2016 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185842